Secondary Hereditary and Acquired Cardiac Channelopathies and Sudden Cardiac Death -- Cardiac Remodeling -- Arrhythmias and Arrhythmia Management in Hypertrophic Cardiomyopathy -- Sudden Cardiac Death in Dilated Cardiomyopathy and Skeletal Muscular Dystrophy -- Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia -- Wolff-Parkinson-White Syndrome and the Risk of Sudden Death -- Acquired (Drug-Induced) Long and Short QT Syndromes -- Acquired Form of Brugada Syndrome -- Clinical Rhythmology: Diagnostic Methods and Tools -- Abnormal Electrical Functions of the Heart and Their Diagnoses in Clinic -- Diagnostic Electrocardiography -- Microvolt T Wave Alternans: Mechanisms and Implications for Prediction of Sudden Cardiac Death -- Heart Rate Variability: Measurements and Risk Stratification -- Orthostatic Challenge Tests: Active Standing and Head-Up Tilt -- Signal Averaged ECG Surface Mapping and Magneto-Electrocardiography -- Ambulatory Monitoring: Holter, Event Recorders, External, and Implantable Loop Recorders and Wireless Technology -- Device Therapy for Remote Patient Management -- Invasive Electrophysiologic Testing: Role in Sudden Death Prediction -- Provocative (Drug) Testing in Inherited Arrhythmias -- Novel Predictors of Sudden Cardiac Death -- Genetic Testing -- Risk Stratification of Sudden Cardiac Death in Acquired Clinical Conditions -- Screening for Risk of Sudden Cardiac Death -- Risk Stratification for Sudden Death in Patients with Coronary Artery Disease -- Sudden Death in Athletes -- Cardiac Channelopathies and Sudden Infant Death Syndrome -- Heart Failure and Sudden Death -- Neurologic Conditions and Sudden Death -- Sudden Cardiac Death and Alcohol -- Sudden Cardiac Death and Addictive Chemical Substances -- Obstructive Sleep Apnea and Sudden Death -- Sudden Cardiac Arrest in Chronic Kidney Disease -- Clinical Trials in Sudden Cardiac Death Prevention: Principles and Endpoints.-Treatment and Prevention Modalities -- Treatment Modalities -- Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death -- Non-Antiarrhythmic Drugs in Sudden Death Prevention -- Non-Surgical Treatment and Prevention of Atrial Fibrillation -- Surgical Treatment of Atrial Fibrillation -- Catheter Ablation for Triggered Ventricular Fibrillation and Polymorphic Ventricular Tachycardia -- Catheter Ablation for Scar-Dependent Ventricular Tachycardia -- The Implantable Cardioverter Defibrillator: Technical and Clinical Considerations -- Beyond Sudden Death Prevention: Minimizing ICD Shocks and Morbidity, and Optimizing Efficacy -- Pacing and Cardiac Resynchronization.